- Approval Id
- 6ebf36a92cfe88cc
- Drug Name
- TELFAST TABLET 180 MG
- Product Name
- TELFAST TABLET 180 MG
- Approval Number
- SIN11699P
- Approval Date
- 2001-10-27
- Registrant
- OPELLA HEALTHCARE SINGAPORE PTE. LTD.
- Licence Holder
- OPELLA HEALTHCARE SINGAPORE PTE. LTD.
- Drug Type
- Therapeutic
- Forensic Classification
- PRESCRIPTION ONLY MEDICINES
- Dosage Form
- TABLET, FILM COATED
- Dosage
- <p><strong>Dosage and method of administration</strong><br>
<strong>Adults and children aged 12 years and older</strong><br>
The recommended dose is one tablet once daily.</p>
<p><strong>Special risk groups</strong><br>
Studies in special risk groups (elderly, renally or hepatically impaired patients) indicate that it is not necessary to adjust the dose of fexofenadine hydrochloride in these patients.</p>
- Route Of Administration
- ORAL
- Indication Info
- <p><strong>Indications</strong><br>
<strong>Telfast 180mg</strong> is indicated for the relief of symptoms associated with Seasonal Allergic Rhinitis (SAR) and Chronic Idiopathic Urticaria (CIU) in adults and children 12 years of age and older.</p>
- Contraindications
- <p><strong>Contraindications</strong><br>
Fexofenadine is contraindicated in patients with known hypersensitivity to any of its ingredients.</p>
- Atc Code
- R06AX26
- Atc Item Name
- fexofenadine
- Pharma Manufacturer Name
- OPELLA HEALTHCARE SINGAPORE PTE. LTD.
- Company Detail Path
- /organization/opella-healthcare-singapore-pte-ltd
